Navigation Links
Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease
Date:8/28/2007

yndrome (AMS) has been reported to occur infrequently in association with IGIV treatment. Discontinuation of IGIV treatment has resulted in remission of AMS within several days without sequelae.

Various mild and moderate reactions, such as headache, fever, fatigue, chills, flushing, dizziness, urticaria, wheezing or chest tightness, nausea, vomiting, rigors, back pain, chest pain, muscle cramps, and changes in blood pressure may occur with infusions of Immune Globulin Intravenous (Human).

GAMMAGARD S/D

[Immune Globulin Intravenous (Human)]

GAMMAGARD S/D is indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. These include but are not limited to congenital X-linked agammaglobulinemia, common variable immunodeficiency, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.

GAMMAGARD S/D must not be used in patients with selective IgA deficiency (IgA, 0.05 g/L) where the IgA deficiency is the only abnormality of concern.

Important Safety Information

Patients may experience severe hypersensitivity reactions or anaphylaxis in the setting of detectable IgA levels following infusion of GAMMAGARD S/D.

Immune Globulin Intravenous (Human) products have been reported to be

associated with renal dysfunction, acute renal failure, osmotic nephrosis,

and death. Patients predisposed to acute renal failure include patients

with any degree of pre-existing renal insufficiency, diabetes mellitus,

age greater than 65, volume depletion, sepsis, paraproteinemia, or

patients receiving known nephrotoxic drugs. Especially in such patients,

IGIV products should be administered at the minimum concentration

available and the minimum rate of infusion practicable. While these

reports of renal dysfunction and acute renal failure have been associated

with the use of many of the licensed IGIV products, those containing

sucros
'/>"/>

SOURCE Baxter International Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
2. Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
3. Cortex Area Thinner in Youth with Alzheimers-Related Gene
4. Appendicitis: Evolving Tools to Diagnose a Classic Disease
5. Non-Invasive Diagnostic Tests for Celiac Disease
6. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimers Disease
9. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
10. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
11. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2015)... , March 1, 2015  Patients suffering from ... against this debilitating foot ailment, according to research ... ,s Annual Scientific Meeting . Researchers utilized ... emulsify and remove diseased fasciitis tissue. Permanently removing ... to regrow in its place, restoring normal function. ...
(Date:2/27/2015)... 27, 2015 Pharmaceutical and biotech marketers are ... for the same indication. This can be a complex ... prevent one of their brands from gaining market share ... recent research by benchmarking firm, Best Practices, LLC, 75% ... rather than together as part of a franchise. Marketers ...
(Date:2/27/2015)... NEW YORK , Feb. 27, 2015  Pomerantz ... Vitae Pharmaceuticals, Inc. ("Vitae" or the "Company") (NASDAQ: ... Robert S. Willoughby at rswilloughby@pomlaw.com ... whether Vitae and certain of its officers and/or directors ... Exchange Act of 1934.  On February ...
Breaking Medicine Technology:Interventional radiology treatment relieves chronic plantar fasciitis 2Interventional radiology treatment relieves chronic plantar fasciitis 3New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2
... ,, HARBIN, China , July ... the "Company"), a,developer, manufacturer and distributor of botanical products,bio-pharmaceuticals and traditional ... common stock on the NYSE Amex. , ... Renhuang expects to ...
... 1 Hanger Orthopedic Group, Inc. was recently ... the January 12th earthquake in Haiti ... development and humanitarian nongovernmental organizations.  Presented with InterAction,s Corporate ... by Physicians for Peace, an InterAction member organization and ...
Cached Medicine Technology:Renhuang Pharmaceuticals Receives Approval to List on the NYSE Amex 2Renhuang Pharmaceuticals Receives Approval to List on the NYSE Amex 3Hanger Orthopedic Group Honored for its Charitable Relief Efforts in Haiti by InterAction 2Hanger Orthopedic Group Honored for its Charitable Relief Efforts in Haiti by InterAction 3
(Date:3/2/2015)... 02, 2015 The Alliance for Bangladesh ... expert Mark Chubb to serve as chief safety officer. ... and training in Bangladesh and guide remediation efforts in ... “Mark will ensure that the Alliance continues to bring ... for Bangladesh garment workers,” said Alliance Independent Chair Ellen ...
(Date:3/2/2015)... ProvidaStaff has announced today that ... division to EDU Healthcare to reflect better ... systems and students nationwide. , “ProvidaStaff has always been ... the country,” said Angela M. Lewis, President of ProvidaStaff. ... and the introduction of EDU Healthcare better aligns our ...
(Date:3/2/2015)... Viejo, California (PRWEB) March 02, 2015 ... release of the TranStatic Volume 2 from Pixel Film Studios. ... transitions made exclusively for FCPX,” said Christina Austin, CEO of ... to have in any Final Cut Pro X editors toolbox.” ... scene to the next with media altering static scrambling effects ...
(Date:3/1/2015)... 2015 To help healthcare ... their practices compliantly and profitably, MDreferralPRO and ... The interoperability between a strategic referral ... practice management system is necessary for a ... A referral management and development solution relies ...
(Date:3/1/2015)... As residents and business owners in ... and Carita Weaver, believe in supporting local organizations ... Southlake Chamber of Commerce, Carroll Independent School District ... a website for Southlake mayoral candidate Laura Hill: ... for Hill’s campaign, the website combines images, videos ...
Breaking Medicine News(10 mins):Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 2Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 3Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 4Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2
... revealed that vaccines that contain mercury do not ... Center scientists examined patterns between the developmental disorder ... findings in the journal Pediatrics. ,Their ... in children given shots after thimerosal, a mercury-based ...
... has laid unbelievable blunders on the table which speaks of ... just escaped by the skin of their teeth//. ,There ... simply unable to fathom the losses for which they are ... to a million ,The slip ups range from ...
... named menin – involved in tumor-suppression or cell-proliferation-suppressing function ... again affected blood sugar// regulation - researchers at the ... ,In humans menin gene (Men1) mutation can lead to ... (MEN1) and this discovery also has implications for diabetes ...
... been improvements in maternity care, specifically to section 88 ... to which expectant mothers prefer care of midwives over ... go far enough in bringing pregnant women back to ... the New Zealand Medical Association's GP council, said "They ...
... Medicine and Lucile Packard Children’s Hospital claim that they ... Down syndrome, in a gene that causes neurons in ... memory. ,The researchers in US have explained ... that, if over-produced, could cause certain brain cells to ...
... Robert Wood Johnson Medical School in New Brunswick, New ... likely to indulge in bed wetting //as children since ... ,"There is biological plausibility in inferring that breast-feeding protects ... association,” the researchers said. They added that there was ...
Cached Medicine News:Health News:Menin Gene Mutation made Insulin Secreting Cells to Proliferate 2Health News:Stanford Researchers Identify A Gene Causing Downs Syndrome 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: